Serpinc1 irna compositions and methods of use thereof

ZA202503746BActive Publication Date: 2026-08-26GENZYME CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
ZA202503746
Authority / Receiving Office
ZA · ZA
Patent Type
Patents
Current Assignee / Owner
Priority Date
2013-03-15
Filing Date
2025-05-02
Publication Date
2026-08-26
Estimated Expiration
2045-05-02
Patent Text Reader

Abstract

The invention relates to iRNA, e.g., double- stranded ribonucleic acid (dsRNA), compositions targeting the Serpinc1 gene, and methods of using such iRNA, e.g., dsRNA, compositions to inhibit expression of Serpinc1 and methods of treating subjects having a bleeding disorder, such as a hemophilia.
Need to check novelty before this filing date? Find Prior Art